mainstreaming examples - European Cluster Collaboration Platform

Emilie ROMEO
De:
Envoyé:
À:
Objet:
Claire Skentelbery <[email protected]>
lundi 3 novembre 2014 12:53
Claire Skentelbery
CEBRSpace November: Proposals submitted, new member event calendar,
Internationalisation and Cluster Management Special Interest Groups
CEBRSpace November Cluster proposals submitted, member calendar, internationalisation, biomarker programme and self‐
financing for cluster managers What a busy autumn so far – members have been working hard on the first of several cluster proposal
opportunities, with the Cluster Excellence Programme deadine on October 29. Well done all those clusters that were
part of proposals and best of luck in the evaluation. Any members involved in successful proposals can use CEBR as a
dissemination and project exploitation so that all clusters in Europe can share the benefits of your work or contribute to
project delivery. We have time for a quick recovery before members target the next deadlines due in 2015.
1
Internationalisation Special Interest Group
Member calendar
Follow CEBR member opportunities each month
This is a busy SIG, with work through to summer 2015. Key meetings include:



Webinar ‐ Introduction to Teijin Pharma: November 20. A webinar introduction to our new Associate member which which wishes to network with specific medical device SMEs through cluster managers. This gives CEBR the opportunity to profile member SME medical device profiles and for launch an online directory for greater critical mass and international profile. Members are invited to take part to meet Teijin Pharma and kick start the design of a medical device SME programme Workshop ‐ Global Cluster Biomarker programme: November 25, Munich as part of the 4th Munich Biomarker Conference. CEBR will host a workshop focussing on biomarker funding for SMEs – your biomarker SMEs should be there Webinar ‐ Global Cluster Biomarker programme. 2015 biomarker programme planning: December 4. CEBR members are invited to help plan the biomarker programme for 2015, including its next international showcase. 
November 3: BioXclusters project EU‐Japan Cluster Matchmaking Event at Bio Europe in Frankfurt. 4 leadin
Japanese clusters and the Japan Bioindustry Association
(JBA) will showcase the opportunities for EU clusters an
companies 
November 25‐26: BioM. 4th Munich Biomarker Conference. This meeting covers all stages of biomarker development and has a focus on the translation of academic research findings into industry‐driven drug development plus individualised treatment in the standard of care

December 4: Mediwales (UK) Life Science Industry Conference, Cardiff. 1 day event with over 300 attende
and agenda including Regulatory Update, Open Innovation and big data, Personalised medicine and comanion diagnostics, Regenerative medicine and wound healing. 
December 9: One Nucleus (UK) Genesis Conference, London. In addition to a full B2B meeting, there is a dedicated hub for delegates to Source Internationa
Opportunities, with CEBR members uniquely able to ge
the following: A4 literature on the Source International Opportunities hub, Pre‐event promotion as part of the Source Lounge, Full delegate pass with access to all sessions, materials,
refreshments and the online 1‐2‐1 partnering facility, Web site signage as a supporter of the conference, A 40% discounted delegate rate of £19
for any attending companies from their cluster. Cluster management Special Interest Group
The topic for this SIG over the next year is that of self financing for cluster managers. A critical topic for many clusters and one where shared good practice and recommendations will support clusters across Europe.
 Webinar ‐ Self‐financing for cluster managers: December 10. This webinar will look at how cluster managers should plan for independent revenue streams, protecting their cluster management mission and avoiding commercial conflicts of interest. [email protected]
www.cebr.net
2
Emilie ROMEO
De:
Envoyé:
À:
Objet:
European Cluster Collaboration Platform <[email protected]>
mercredi 5 novembre 2014 08:18
Wehnelt
ECCP Newsletter Oktober 2014
If this email is not displayed in proper style, please click here
Newsletter October 2014
Creating Business
Opportunities in China
through a Mission for
Growth in Chengdu
A step toward a new
European Cluster
Strategy for Growth
bioXclusters: Make use
of this great possibility
to learn about the
strenghts of Japanese
life science landscapes
and clusters in the
health care sector
Join the "Bridging the
Regions in Europe"
Conference!
Cluster Excellence
Management Training
1. European Emerging
Industries Conference
Dear ECCP User,
The European Cluster Conference in Brussels and the Cluster Matchmaking Event in
China took place in October 2014. We would like to provide you the post-reportings of
the events. There are other interesting events open right now for clusters interested in
entering new markets or creating partnerships and networks across borders and
sectors. We compiled a selection of events for you in this newsletter.
For more information and news check out www.clustercollaboration.eu
Best regards,
Your ECCP Team
Creating Business Opportunities in China through a
Mission for Growth in Chengdu
From the 21st to 24th of October 2014, a Cluster Matchmaking Event was
organised in the scope of the "Mission for Growth" to Chengdu (China)This
Event offered a chance for European Clusters to develop collaborations with
participating clusters from China; thus, creating greater possibilities for SMEs
to grow through opportunities such as access to new markets or to new
products and services.
The EU Cluster Matchmaking Event was composed of 15 representatives from
cluster organisations that were willing and committed to participate in a cluster
matchmaking event to Chengdu (China) in the fields of:





Bio-chemicals
Bio-pharmacy & bio-technology
Environmental protection
ICT
Renewable energy
You can find more information on the Event on clustercollaboration.eu.
1
A step toward a new European Cluster Strategy for
Growth
The fourth European Cluster Conference, organised by the European
Commission's Directorate General for Enterprise and Industry, addressed the
role of clusters in support of SME growth, industrial renewal and regional
structural change and competitiveness. It gathered over 340 cluster
stakeholders from across Europe consisting of key policy makers from national
and regional authorities, practitioners and high-level speakers from academia
and industry. Conference participants discussed the latest trends and
challenges for modern cluster policies and worked together to identify priority
areas for a new European Cluster Strategy for Growth.
For more information and news check out www.clustercollaboration.eu. You will
also find detailed information here.
bioXclusters: Make use of this great possibility to learn
about the strenghts of Japanese life science landscapes
and clusters in the health care sector
The EU-Japan Cluster Matchmaking Event – financially supported by the
European Commission (http://www.clustercollaboration.eu/) – is taking place at
Bio Europe in Frankfurt (Germany) on November, 3rd. It provides the perfect
opportunity to gain an overview of the strengths of the Japanese life sciences
landscapes and clusters in the health care sector.
Find more information here.
Join the "Bridging the Regions in Europe" Conference!
Worldwide, the proportion of people aged 60 and over is growing faster than
any other age group: this demographic change represents. Innovative, ITsupported solutions were sought for within the SEE_Innova partnership in
order to find solution for a sensitive problem: keeping elderly people in their
homes as long as possible and support their active ambient living with new
technological tools. What has been reached? Come and find out at the two-day
conference in Budapest.
Detailed information find here.
Cluster Excellence Management Training
The European Foundation for Cluster Excellence has launched its 2015 training
programmes; The Essence of Cluster Excellence Management and Gold Cluster
Excellence Manager. With the support of the European Commission, these
programmes address the need for a more streamlined training format in
addressing the training needs of cluster managers. Both programmes push for
further creativity, innovation and growth in economic clusters.
Find more information here.
1. European Emerging Industries Conference
The first European Emerging Industries Conference "Rinascimento: Emerging
Industries – A New Engine for Growth", organised by the Region of Lombardy
in cooperation with the European Commission's Directorate-General for
Enterprise and Industry in the framework of the Italian Council Presidency will
offer an important opportunity for policy makers, entrepreneurs, SME
intermediaries and other stakeholders to come together and exchange views,
ideas and opinions on Europe's most important resource – innovation.
Find more informations on clustercollaboration.eu
2
Clusterland Oberösterreich GmbH
Hafenstraße 47-51
4020 Linz, Austria
Tel. +43-732-79810-5157
Website: www.clusterland.at
E-Mail: [email protected]
Impossible d'afficher l'image liée. Le fichier a peut-être été déplacé, renommé ou supprimé. Vérifiez que la liaison pointe v ers le fichier et l'emplacement corrects.
3
Impossible d'afficher l'image liée. Le fichier a peut-être été déplacé, renommé ou supprimé. Vérifiez que la liaison pointe v ers le fichier et l'emplacement corrects.
EU-Japan Cluster Matchmaking Even at BioEurope
1 sur 2
HOME
NEWS
EVENTI
DOCUMENTI
http://www.biopmed.eu/index.php?option=com_content&view=article...
CONTATTI
SITEMAP
BIOPMED AWARD
MENU BIOPMED
EU-JAPAN CLUSTER MATCHMAKING EVEN AT BIOEUROPE
SCIENZE DELLA VITA IN
PIEMONTE
POLO BIOPMED
BIOPMED SERVIZI
BIOPMED PROGETTI EUROPEI
PIATTAFORME TECNOLOGICHE
BIO IN PIEMONTE
Venerdì 12 Settembre 2014 12:59
The EU-Japan Cluster Matchmaking Event – financially supported by the European Commission
(http://www.clustercollaboration.eu) – is taking place at Bio Europe in Frankfurt (Germany) on November 3rd, 2014.
It provides the perfect opportunity to gain an overview of the strengths of the Japanese life sciences landscapes and
clusters in the health care sector.
Speakers from four leading Japanese life science clusters and from Japan Bioindustry Association (JBA) will present the
vast array of opportunities that the Japanese pharma and health market offers to European companies.
APPROFONDIMENTI
AREA STAMPA
If you work for a European life science cluster or if you are a manager of a company that targets the Japanese market, do
not miss the opportunity to establish valuable contacts at this event.
It creates the basis for cluster cooperations, R&D projects, licensing opportunities, attracting joint partnerships,
developing small scale, high value manufacturing projects, developing commercial activities and establishing your
presence in the Japanese market by using soft landing facilities.
Download the agenda >>
Your participation is free and no registration is required.
bioPmed è parte di
For more information, please contact us:
Coordinator of the event: BioM Biotech Cluster Development (Germany) http://www.bio-m.org - Dr. Stephanie Wehnelt
[email protected]
Biocat (Spain) – http://www.biocat.cat - Jordi Fàbrega [email protected]
bioPmed (Italy) – http://www.biopmed.eu - Fabrizio Conicella [email protected]
Lyonbiopole (France) - http://www.lyonbiopole.com - Emilie Roméo [email protected]
PROSSIMI EVENTI
27/11/2014
Corso di formazione "La creatività"
27/11/2014
NanotechItaly 2014
28/11/2014
Corso "Promotional Business Writing"
02/12/2014
Forum OCOVA AlpMedNet_Ivrea
02/12/2014
Turkish Pharmaceutical Forum
in partnership con
27/11/2014 18:13
EU-Japan Cluster Matchmaking Even at BioEurope
2 sur 2
http://www.biopmed.eu/index.php?option=com_content&view=article...
Bioindustry Park Silvano Fumero S.p.A. - Bi.P.Ca. S.p.A. - 10010 COLLERETTO GIACOSA (TO) - Via Ribes n. 5 - Tel. +39 0125 561311 - Fax +39 0125 538350 - e-mail [email protected]
Codice Fiscale, Partita IVA e CCIAA To 06608260011 - Registro imprese Torino n. 799923 - Capitale Sociale i.v. Euro 12.581.663
Copyright © 2009-2014 Bioindustry Park Silvano Fumero S.p.A. - Designed by ZioSEM - Hosting by Aethia
27/11/2014 18:13
Emilie ROMEO
De:
Envoyé:
À:
Objet:
Redaktion-GmbH <[email protected]>
jeudi 23 octobre 2014 18:14
Wehnelt
bio-m.org: Newsletter 23.10.2014
Wenn der Newsletter nicht richtig dargestellt wird, klicken Sie bitte hier »
23. Oktober 2014
Sehr geehrte Frau Dr. Stephanie Wehnelt,
Highlights:
passend zum Schmuddelwetter erreicht Sie mit
dem aktuellen BioM Newsletter ein Sonnenstrahl:
gute Nachrichten aus dem und zahlreiche
interessante Veranstaltungen im Münchner
Biotech Cluster!
MorphoSys & Amgen »
Gründerseminar & Patent
Prosecution »
Stellenbörse »
Ihr BioM Newsletter Team
Editorial
News
BioM Events
Termine
Pressemitteilungen
Stellenbörse
Die Münchner Drug-Pipeline macht große Fortschritte! Aber ist das
überhaupt „die Münchner“ Drug-Pipeline, wenn der ehemalige
Micromet-Antikörper nun bei AMGEN schon in Richtung Zulassung
marschiert, oder MorphoSys hocherfreut den nun bereits 3. Antikörper
in einer Phase-3-Studie bei einem der internationalen Pharmapartner
melden kann? Wir sagen ja,...>>mehr
Editorial
News
BioM Events
Termine
Pressemitteilungen
Stellenbörse
MorphoSys hat nun 3 Antikörper in Phase-3 - mit Pharmapartnern
1
Die MorphoSys AG gab nämlich gerade den Start einer
klinischen Phase 3-Studie mit dem HuCAL-Antikörper
Guselkumab (CNTO1959) in moderater bis schwerer
Schuppenflechte durch ihren Partner Janssen Biotech, Inc.
bekannt. Hierdurch wurde die... Mehr »
Made in Munich: Amgen beantragt Antikörper-Zulassung
Der US-amerikanische Biotech-Konzern Amgen hat die
Zulassung für das in München entwickelte Immunmolekül
Blinatumomab beantragt. Erst Ende Juli hatte die USamerikanische Arzneimittelbehörde FDA dem Antikörper
Blinatumomab die begehrte... Mehr »
Careers in Pharma, Biotech, Chemie, Medizin - Karrieretag der LMU
am 29. Oktober
Am 29. Oktober 2014 hat man die Gelegenheit, auf diesem
spezifischen Karriereevent für die Branchen Chemie,
Pharma, Biotech und Medizin am HighTechCampus der
LMU München in Großhadern/Martinsried auf eine ganze
Reihe von jungen und etablierten... Mehr »
NIH/DOD Non-Dilutive Funding Opportunities
Das Seminar am 4. Dezember informiert über
Fördermöglichkeiten in den USA. Das National National
Institute of Health (NIH), Department of Defense (DOD)
und weitere Organisationen in den USA unterstützen F&E
Aktivitäten von Life Science... Mehr »
IDBS Best Practices Forum in München
Das Seminar am 20. November 2014 um 10 Uhr zeigt auf,
wie die IDBS Technologie helfen kann, Innovationen zu
steigern und die Wettbewerbsfähigkeit und Effizienz zu
verbessern. Während dieser halbtägigen Veranstaltung
werden IDBS und Branchenexperten... Mehr »
Mehr News finden Sie unter:
2
www.bio-m.org/news.html »
Editorial
News
BioM Events
Termine
Pressemitteilungen
Stellenbörse
EU-Japan Cluster Matchmaking Event auf der BIO-Europe
BioM lädt alle an Japan interessierten Unternehmen und
Multiplikatoren ein, im Programmrahmen der BIO-Europe
2014 in Frankfurt an dem EU-Japan Cluster Matchmaking
Event teilzunehmen. Am Nachmittag des 3. Novembers
können Sie sich im Raum... Mehr »
BioM-Forum: Global patent prosecution
Fortgeschrittene Strategien für die wirksame und
kosteneffiziente Durchsetzung und Verteidigung von
Patenten. In der wettbewerbsreichen Life Science Branche
ist ein starker und umfassender Patentschutz unerlässlich.
Biotechnologie-Unternehmen... Mehr »
Gründerseminar: Erfahrungsberichte von Life Science Start-Ups &
Informationen zur Gründung
Sie wollen Ihr eigenes Biotech-Start-Up gründen und
möchten wissen, was alles zu einer erfolgreichen
Unternehmensgründung dazugehört?Dann laden wir sie
ein zu unserer Veranstaltung:"Wecke die Gründerin in
Dir!Wecke den Gründer in... Mehr »
Mehr News finden Sie unter:
www.bio-m.org/news.html »
Partner Event
3
Editorial
News
BioM Events
Termine
Pressemitteilungen
Stellenbörse
04.11.2014
Klinische Studien für Medizinprodukte »
13.11.2014
How much do we pay for expensive cancer medicines and personalized
medicine? »
17.11.2014
Innovationsakademie Biotechnologie »
Mehr Termine finden Sie unter:
www.bio-m.org/veranstaltungen/termindatenbank.html »
Editorial
News
BioM Events
Termine
Pressemitteilungen
Stellenbörse
13.10.2014
ImevaX GmbH
Erfolgreiche Ausgründung der ImevaX GmbH aus der Technischen
Universität München (TUM) und Förderung durch das Bundesministerium für
Bildung und Forschung (BMBF) in Höhe von EURO 5,9 Mio. »
21.10.2014
XL-protein GmbH
YEDA and XL-protein sign business collaboration agreement to
commercialize PASylated interferon superagonist »
22.10.2014
NanoTemper Technologies GmbH
NanoTemper Technologies acquires SAW Instruments »
Mehr Pressemitteilungen finden Sie unter:
www.bio-m.org/pressemitteilungen.html »
Editorial
News
BioM Events
Termine
Pressemitteilungen
Stellenbörse
20.10.2014
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit
und Umwelt (GmbH)
Wissenschaftler/in Biostatistik 2014/2551 »
20.10.2014
KLIFOVET AG
4
Vorstandsassistenz (m/w)»
23.10.2014
Hyglos GmbH
Biotechnologe/in R&D (m/w)»
23.10.2014
Roche Diagnostics GmbH
Biologielaborant (m/w)»
23.10.2014
ethris GmbH
Technische Assistenz (m/w)»
Mehr Stellen finden Sie unter:
www.bio-m.org/stellenboerse.html »
Sie haben Anregungen, Wünsche, Kritik?
Dann nehmen Sie Kontakt mit uns auf. Das Redaktionsteam wird sich umgehend darum kümmern:
[email protected]
Sie möchten den BioM Newsletter abbestellen?
Falls Sie diesen Onlineservice ungewollt erhalten, bitten wir Sie, dies zu entschuldigen. Wenn Sie aus allen
BioM Verteilern entfernt werden möchten, benutzen Sie bitte diesen Link ».
Impressum
BioM Biotech Cluster Development GmbH
Am Klopferspitz 19a
82152 Martinsried
Telefon: +49 (0) 89/ 89 96 79-0
Telefax: +49 (0) 89/ 89 96 79-79
E-Mail: [email protected]
Geschäftsführer: Prof. Dr. Horst Domdey
Registergericht: Amtsgericht München
Registriernummer: HRB 16 37 43
Inhaltlich Verantwortlicher gemäß § 10
Absatz 3 MDStV: Prof. Dr. Horst Domdey
(Am Klopferspitz 19a, 82152 Martinsried)
Haftungshinweis: Trotz sorgfältiger inhaltlicher Kontrolle übernehmen wir keine Haftung für die Inhalte externer
Links. Für den Inhalt der verlinkten Seiten sind ausschließlich deren Betreiber verantwortlich.
BioM Biotech Cluster Development GmbH · Am Klopferspitz 19a · 82152 Martinsried · [email protected]
5
Twenty-two Catalan companies to participate in BIO-Europe Frankfurt...
1 sur 1
http://www.biocat.cat/en/news/twentytwo-catalan-companies-participa...
Català
Español
News
Twenty-two Catalan companies to participate in BIO-Europe Frankfurt
At the congress there will be an EU-Japan partnering event organized by BioXclusters, an alliance of which Biocat is a
member
(http://www.addthis.com/bookmark.php?v=250&username=xa-4b699392151c15f0)
15.10.2014 |
(http://www.biocat.cat/sites/default/files
/BIO_Europw.jpg.crop_display.jpg)
The number of one-to-one partnering
meetings at BIO-Europe 2014 is expected
to beat the record set in 2013. - © EBD
Group
0 comments (#comentari)
The twentieth edition of BIO-Europe (http://www.ebdgroup.com/bioeurope/index.php) , one of the largest European partnering congresses for
the biotechnology and pharmaceutical arena, will be held from 3 to 5 November in Frankfurt (Germany). 22 Catalan companies
will travel to the fair, similar to the number that participated in the 2013 congress in Vienna.
The organizers of the congress, EBD Group (http://www.ebdgroup.com/) , expect the number of one-to-one partnering meetings held this
year to beat the all-time record set in 2013. BIO-Europe 2013 hosted 184 company presentations and more than 3,200 delegates
from 1,814 companies representing 56 different countries.
You can follow BIO-Europe 2014 on Twitter with the hashtag #BEU12 (https://twitter.com/search?q=%23BEU12&src=typd) or online in the Life
Science
Partnering
discussion
forum
(http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbit.ly%2F1plgSdZ&esheet=50958393&
newsitemid=20141008006132&lan=en-US&anchor=Life+Science+Partnering+discussion+forum&index=6&md5=c797baff1ffb210f87d5658e2c2ba385) .
EU-Japan Cluster Matchmaking Event
Under the framework of the BIO-Europe fair, a partnering event between Europe and Japan will be held on 3 November. The
EU-Japan Cluster Matchmaking Event (http://bioxclusters.eu/2014/09/12/eu-japan-cluster-matchmaking-even-at-bioeurope-3rd-november-2014/) has
received financial support from the European Commission and is being organized by the BioXclusters (http://bioxclusters.eu/) alliance.
Biocat, as a BioXclusters partner, is helping organize the event along with clusters BioM Biotech Cluster Development (http://www.biom.org/)
(Germany), bioPmed (http://www.biopmed.eu/) (Italy) and Lyonbiopole (http://www.lyonbiopole.com/) (France).
This matchmaking event offers participants an overview of the strengths and current status of Japanese life sciences groups from
the healthcare sector, as well as laying the groundwork for future collaborations, R&D projects or commercial activities in the
Japanese market.
At the event, clusters Metropolitan Bionetwork (http://www.jba.or.jp/syutokenbio/en/) (Tokyo), Yokohama-Kanagawa Bio-Business network
(https://www.yk-bio.net/en/)
(Kanagawa), Protein Mall Kansai (http://www.osaka-bio.jp/en/) (Osaki), Fukuoka BioCluster Project (http://www.biocat.cat
/sites/default/files/Fukuoka_BioValley_Project.pdf)
(Fukuoka) – the four main Japanese life sciences cluster groups – and the Japan
Bioindustry Association (http://www.jba.or.jp/pc/en/) (JBA), will present a wide range of opportunities available for European companies in
the Japanese pharmaceutical and healthcare market.
On a related note, the registration period is now open for those interested in giving a company presentation at BIO-Europe Spring
2015 (http://www.ebdgroup.com/bes/index.php) , which will be held in Paris from 9 to 11 March. The deadline to submit applications
(http://www.ebdgroup.com/bes/presenters/index.php) is
28 November 2014.
27/11/2014 18:11
http://lyon-bio-pole.fr/admin/modules/newsletter/newsletter_show.php...
To watch that newsletter in your browser, click here
Subscribe to the newsletter
Contact
|
www.lyonbiopole.com
11/28/2014 Lyonbiopole Private
Inv€stment Day's 6th
edition
For the 6th time, Lyonbiopole organizes the Private
Inv€stment Day on Friday, November 28th 2014, from 8.00
am to 3.00 pm. This event, dedicated to SMEs and private
investors, aims to foster interactions between companies,
new entrepreneurs and investors of various kind. This day
will be organized around moments of networking
(roundtables, testimony and breaks) and company and
project presentations.
Contact: Kevin Romani, SMEs Developement Director
- [email protected]
November 2014
10/2014 - Horizon 2020 Health Calls for projects open
Several calls for projects in the H2020 "Health, demographic change and
well-being" challenge, are open ("Calls H2020-PHC-2015 one-step" are still
open: deadline 2/24/2015). They are designed to support collaborative projects
to improve the quality of life of European citizens and the economic viability of
health systems. Other calls related to health (like NMP program) or
multidisciplinary programs like FET (Future Emerging Technologies) are open.
More information here
Contact: Emilie Romeo, European Project Manager [email protected]
10/2014 - IMI 2 call for projects open
10/10/2014 - Partnering
Day and BlueSky
Meeting 2014
Stimulating innovation was the leitmotif of this new edition of
Lyonbiopole Partnering Days held at the WTC Grenoble
Friday, October 10th. A majority of the cluster's members from
Lyon and Grenoble neraly 250 participants attended the event
to incite the emergence of tomorrow's public/private R&D
partenrship. The program is structured around three key
moments: 14 brainstorming roundtables, the BlueSky
Meeting with the presentation of 20 innovative technological
products and ideas for collaborative projects and, finally, a
three industrial groups discussion on open innovation
and R&D collaborative strategies.
Contact: Claudia Chagneau, R&D Project Manager [email protected]
The Innovative Medicines Initiative (IMI) launched its first call for projects under
the IMI 2 on July 9. The topics proposed in the first call are: - Translational
Approaches to disease modifying therapy of type 1 diabetes mellitus Discovery and validation of novel endpoints dry age-related macular
degeneration and diabetic retinopathy. Deadline for submission: November 12,
2014. IMI encourages the participation of SMEs, patient organizations,
regulatory authorities, academic teams, industry, hospitals and other
organizations. Lyonbiopole supports you to build up European projects
Contact: Emilie ROMEO, European Project Manager - [email protected]
Learn more
10/2014 - H2020 SME Instrument
H2020 program includes the SME instrument. It aims to fill gaps in the high-risk
funding of innovation and give a strong boost to reach innovation. It targets the
highly innovative SMEs with a strong ambition to develop, grow and
internationalize; focusing on the delivery of new products, services or
processes on the market. For SMEs in the health sector, the SME instrument is
focused on the PHC-12 Clinical research for the validation of biomarkers and /
1 sur 3
27/11/2014 18:08
http://lyon-bio-pole.fr/admin/modules/newsletter/newsletter_show.php...
10/7-8/2014
- Lyonbiopole
announces its
collaboration with
MLSC
Lyonbiopole strengthens its presence in Boston and
announces its collaboration with the Massachusetts Life
Science Center. As part of the United States East Coast
Mission led by Gérard Collomb, Mayor of Lyon and President
of Greater Lyon organized by ONLYLYON, Lyonbiopole and
the MLSC (Massachussets Life Sciences Center) announce
collaboration for setting up collaborative projects under the
"Universal partnership program".
Contact: Kevin Romani, SME's Devlopment Director [email protected]
or diagnostic medical devices line. The project can be presented by a single
SME, and different phases depending on the maturity of the project. Reminder
of deadlines in 2014: Phase 1 & 2 projects = 12/17/2014. Lyonbiopole supports
you to build up European projects.
Contact: Emilie Romeo, European Project Manager [email protected]
Learn more
10/13-17/2014 - Trade mission
during BIO Japan
Erytech Pharma
Erytech Pharma, a bio-pharmaceutical company and a
Lyonbiopole member, is specialized in encapsulation. The
company has just completed a fundraising of € 30 million on
Euronext and announced at the same time the positive
Phase III results from its pivotal study with GRASPA® in the
treatment of acute Lyomphoblastic Leukemia. Rewarded on
21 October 2014 by EuropaBio 's Most Innovative European
biotech SMEs trophy, Erytech now heads to the United
States with a new patent pending in the area of
asparaginase.
With more than 6000 partnering meetings over 3 days, and a fair
representation of Western and Eastern companies, BIO Japan is now one of
the main partnering event in Asia. 4 members of Lyonbiopole participated
to the trade mission organized by the French Trade Agency Ubifrance/DGE.
It was the largest French delegation during BIO Japan. Beside their
participation to BIO Japan, the participants also had the chance to visit the
Takeda Corporate R&D center, in order to gain insight on the Japanese
market, whici is still the 3rd market in the world, and to present their
company at BIO Japan, during a seminar dedicated to France.
Contact: Simon Gudin, SMEs Development Project Manager
- [email protected]
Learn more
10/29/2014 - ImmunID to present at
Cavendish Global Health Impact
Forum
ImmunID, an immune molecular diagnostics company, announced it will be
presenting at the Cavendish Global Health Impact Forum taking place
November 10-13th at Oxford University in the United Kingdom. The Forum's
aim is to help family offices and foundations to develop and implement their
individual pro-social impact investing, grant-giving, and philanthropy
programs within the health sector and the life sciences.
Learn more
11/03/2014 - Meet major
health actors in Japan
on the occasion of Bio
Europe (Frankfurt)
Lyonbiopole and its bioXclusters European partners (Biocat,
bioPmed and BioM) organize on November 3rd, 2014 (from
15:00 to 18:00), during BIO Europe (Frankfurt) a meeting
between Japanese and European players of the Health
sector. This session provides a unique opportunity for
European companies and clusters participating to the
BIO-Europe fair to get an overview of the strengths of the
health sector in Japan and to forge links with the Association
of bio-industries in Japan (JBA), gathering the four major
national clusters and their companies.
Contact: Emilie Roméo, European Project manager
[email protected]
Learn more
11/12-15/2014 MEDICA-COPAMED
Exhibition
Lyonbiopole and I-Care Cluster, in partnership with
UbiFrance invite companies of the Rhône-Alpes region to
participate to MEDICA COPAMED-2014 Exhibition wich will
2 sur 3
27/10/2014 - France’s National
Research Agency selects the
OPTIVAC project
Imaxio announced that it has been awarded of a 600K€ funding by the
French National Research Agency for the OPTIVAC project: “leveraging On
t-cell immune resPonse To Improve influenza VACcines”. The aim of the
OPTIVAC project is to improve the efficacy of vaccines for seasonal influenza
and current pandemics. To achieve this, it will develop a candidate vaccine
made of a recombinant, proprietary, and highly immunogenic version of the
influenza virus nucleoprotein (NP).
Learn more
10/20/2014 - Calixar and Aston
University together in
collaborative research to tackle
multidrug resistance targets
The annual CASE competition for collaborative training awards provides
students with a first-rate research training experience, allowing top quality
bioscience graduates to undertake research, leading to a PhD.
Learn more
27/11/2014 18:08
http://lyon-bio-pole.fr/admin/modules/newsletter/newsletter_show.php...
be held from November 12th to 15th 2014 in Düsseldorf
(Germany). Attend Europe's largest conference on
MedicalesTechnologies & Medical Devices theme.
Contact: Simon Gudin, SMEs Development Project Manager
10/14/2014 - Imaxio signs an
option for a license agreement
with the DKFZ
- [email protected]
Learn more
11/19/2014 - Open
Innovation Day with
Becton Dickinson
Are you targeting the MedTech market? This day will give you
unique opportunity to get valuable information about the
Market segments addressed by BD, the products, and the
innovation targets of some of the business units from BD
Medical and BD Diagnostics segments and to hear about their
R&D fields of interest and technological road map overview.
You should also present your unique and innovative
capabilities and know-how (pitch session and/or speed
meeting).
Contact: Simon Gudin, SMEs Devlopment Project Manager [email protected]
Learn more
Imaxio announces that it has signed an option for a license agreement with
the world-renowned German Center for Cancer Research (DKFZ –
Deutsches Krebsforschungszentrum), based in Heidelberg. The financial
terms of the agreement were not disclosed.
Learn more
10/06/2014 - CleveXel Pharma to
license two new oncology patents
CleveXel Pharma, a highly experienced pharmaceutical developer that
conforms fully with global regulatory compliance, announces that it has been
granted a license by the SATT Sud Est, a technology transfer accelerator in
South Eastern France (Societe d’Acceleration du Transfert de Technologies
Sud Est), to exploit two patents.
Learn more
Bio-Europe 2014
From November 3rd to 5th, 2014 - Frankfurt, Germany
Medica Copamed
From November 12th to 15th 2014 - Dusseldorf, Germany
EnterNext Tech Conference
November 17th, 2014 - Paris , France
4th Munich Biomarker Conference
From November 25th to 26th, 2014 - Munich, Germany
Private Inv€stment Day
November 28th, 2014 - Lyon, France
Biovision 2015
From April 15th to 16th, 2015, Lyon - France
2015 BIO International Convention
From June 15th to 16th, 2015, Philadephia - US
© Lyonbiopole 2014 | CREDITS | LEGAL NOTICE | UNSUBSCRIBE
3 sur 3
27/11/2014 18:08